id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-339727-q8pjwl3s	Sahu, Kamal Kant	Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside	2020-07-30		.txt	text/plain	3325	214	48	Recently, research exploring the therapeutic application of mesenchymal stem cells (MSCs) in critically ill patients suffering from COVID-19 has gained momentum. Recently, research exploring the therapeutic application of mesenchymal stem cells (MSCs) in critically ill patients suffering from COVID-19 has gained momentum. [6] [7] [8] [9] [10] Recently, a few studies have examined the role of mesenchymal stem cells (MSCs) in critically ill patients with COVID-19. Because H7N9 and SARS-CoV-2 share similar complications-ARDS, hypoxic respiratory failure, severe inflammation, overt immune response, and multiorgan dysfunction syndrome-MSCs therapy may be beneficial for patients with COVID-19 pneumonia as well. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use	./cache/cord-339727-q8pjwl3s.txt	./txt/cord-339727-q8pjwl3s.txt